The immunoevasive subtype of cervical cancer and the patient subpopulation of CD8+ T cells with high CD39 expression, due to enhanced CD39 enzymatic activity leading to excessive ADO production, drive immune evasion and poor prognosis. The gene discussed is ENTPD1; the disease is cervical cancer.